Embryonic Induced Pluripotent Stem Cell Differentiation: Pathways and Lineage-Specific Markers
Embryonic induced pluripotent stem cells (iPSCs) hold immense potential in the field of regenerative medicine due to their ability to differentiate into various cell types. Understanding the differentiation pathways and identifying lineage-specific markers are crucial for advancing stem cell research and therapy.
Overview of Embryonic iPSC Differentiation:
Embryonic iPSCs are characterized by their pluripotency, the ability to differentiate into any cell type of the three primary germ layers: ectoderm, mesoderm, and endoderm. This pluripotency is maintained through specific transcription factors such as Oct4, Sox2, and Nanog. The differentiation process involves a complex interplay of these factors, leading to the specialization into various cell lineages.
Figure: Embryonic Induced Pluripotent Stem Cell Differentiation Pathways & Lineage Specific Mark
Ectoderm Differentiation:
Mesoderm Differentiation:
The mesoderm, the middle germ layer, forms the heart, blood, bone, and muscles. T (Brachyury) is a primary marker for mesodermal differentiation, signifying the development of mesenchymal stem cells, cardiac cells, and hematopoietic lineages.
Endoderm Differentiation:
The endoderm forms internal structures such as the lungs, liver, and pancreas. Sox17 is a crucial marker for endodermal differentiation, guiding the development of hepatocytes and pancreatic cells.
Significance and Applications:
Understanding these differentiation pathways and markers is pivotal for stem cell-based therapies. It allows for the precise development of desired cell types for treating various diseases, such as diabetes, Parkinson’s, and heart disease.
Conclusion:
References
- Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
- Thomson, J. A., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
- Boyer, L. A., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122(6), 947-956.
- Chambers, I., et al. (2009). Nanog safeguards pluripotency and mediates germline development. Nature, 450(7173), 1230-1234.
- Murry, C. E., & Keller, G. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132(4), 661-680.
- Loh, Y. H., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics, 38(4), 431-440.
- Avilion, A. A., et al. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes & Development, 17(1), 126-140.
- Tam, P. P., & Loebel, D. A. (2007). Gene function in mouse embryogenesis: get set for gastrulation. Nature Reviews Genetics, 8(5), 368-381.
Written by Tehreem Ali
Tehreem Ali completed her MS in Bioinformatics and conducted her research work at the IOMM lab at GCUF, Pakistan.
Recent Posts
-
MycoGenie Rapid Mycoplasma Detection Kit (MORV0011): Published Uses
SummaryThe MycoGenie Rapid Mycoplasma Detection Kit (MORV0011) is a one-hour, single-temperature …22nd Nov 2026 -
Mouse Kynurenine ELISA Kit (MOFI01315): Published Uses
SummaryAssay Genie's Mouse KYN (Kynurenine) ELISA Kit (MOFI01315) is a competitive ELISA that has …22nd Nov 2026 -
IL-6 ELISA Kit: 14 Studies in Rat, Mouse and Human Samples
SummaryAssay Genie IL-6 sandwich ELISA kits, and one sandwich chemiluminescent immunoassay (CLIA) …21st Nov 2026